Bakshi Finance — Family Office
The information presented on this site is provided for informational and educational purposes only. It does not constitute investment advice, investment marketing, or a substitute for personalised advice. The firm operates as a Family Office serving qualified investors. The firm’s founder held a licensed investment-advisory practice from 2008 through 2023. This site does not participate in the investment decision.

קווליטאו

Qualitau Ltd. | TASE | Semicap Niche

Data as of: April 2026 | Primary source: דוח Annual 2025

QLTU
Research Depth · Standard Semicap · Niche Israeli
Revenue 2025
$61.3M
+32.5% Y/Y
Net Income 2025
$21.6M
+55.2% | EPS $4.81
Operating Margin 2025
39.7%
2024: 34.7%
Gross Margin 2025
71.2%
2024: 67.1%
Order Backlog (Mar 2025)
$57.6M
+200% over two years
Employees
72
Capacity to $70M without additions
1 Company Profile

קווליטאו (QLTU) היא חברה ישראלית שמפתחת, מייצרת ומשווקת ציוד בדיקת אמינות (Reliability Testing) לתעשיית המוליכים למחצה. קווליטאו היא דוגמה ייחודית לחברה ישראלית קטנה שתופסת נישה גלובלית — שחקנית מובילה בעולם בציוד בדיקת אמינות ל-Fab של שבבים, עם בסיס לקוחות מרוכז במזרח הרחוק (TSMC, Samsung, Intel, ועוד). מוצרים: MIRA, INFINITY, ACE, A300SAP, מערכות מתח גבוה (עד 3,000V). 72 עובדים בלבד (2024). מטה בישראל. דיווח ב-USD. נסחרת ב-TASE. ההכנסות גדלו מ-$22.5M ב-2020 ל-$61.3M ב-2025 — צמיחה של 172% בחמש שנים. כוח אדם קטן יחסית למחזור — קווליטאו טוענת שיכולה להגיע ל-$70M הכנסות ללא הגדלת כוח אדם.

מוצר תחום
MIRAבדיקת אמינות מערכות
INFINITYבדיקה משולבת
ACEבדיקת ביצועים
A300SAPפלטפורמה אנליטית
מתח גבוה (3,000V)בדיקת מתח גבוה
מערכות שולחניותפתרונות קטנים

מקור: דוח Annual 2025

2 Key Financial Observations

This summary is not a recommendation. It is a factual list of key financial metrics.

ביצועים — 6 שנים ($M)

שנה הכנסות צמיחה
202022.5-15.7%
202129.1+29.0%
202241.2+41.7%
202341.1-0.1%
202446.2+12.5%
202561.3+32.5%

רווחיות 2024-2025 ($K)

Metric 2024 2025
הכנסות46,24761,258
רווח גולמי31,047 (67.1%)43,636 (71.2%)
רווח תפעולי16,041 (34.7%)24,343 (39.7%)
Net Income13,907 (30.1%)21,574 (35.2%)
EPS בסיסי$3.19$4.81
EPS מדולל$3.02$4.68

Missing data: Insider ownership מדויק, אופי הקצאה הפרטית 225M ₪ (פברואר 2026), תרומה לפי לקוח (TSMC, Samsung, Intel).

הכנסות — 6 שנים ($M)
שולי רווח (%)
Net Income + EPS
Quarterlyות 2025 ($M)
צבר הזמנות
תזרים והקצאת הון
3 Industry & Competitive Context

ציוד בדיקת אמינות למוליכים למחצה — נישה מתמחה. מבנה ריכוזי — קווליטאו מובילה. מגמות: צמיחה ב-AI/5G/automotive; מעבר ל-Advanced Packaging דורש בדיקות חדשות; טכנולוגיות 2nm; סיכון: מלחמת סחר ארה"ב-סין.

מתחרה הבדל מרכזי
Outermost Technologyמתחרה ישיר בנישה
KLAסגמנטים שונים — בקרת תהליכים רחבה
Keysightציוד מדידה כללי
4 Risk Factors
RiskContext
תלות ביצרני שבבים מוביליםTSMC, Samsung, Intel — שינוי ב-Capex של אחד = פגיעה משמעותית
מחזוריות סמיקונדקטור2023 ירד 0.1% — מחזורי ירידה אפשריים
מגבלות ייצוא לסיןחלק גדול מהמכירות במזרח הרחוק
Q4 2025 — חולשה לאחר Q3 שיאQ3: $21.1M → Q4: $12.0M (-43%) — דורש מעקב
הקצאה פרטית 225M ₪דילול ~7.5% — לאיזו מטרה?
גודל קטן72 עובדים — תלות בכמה אנשי מפתח
תחרות מ-Outermostמתחרה ישיר בנישה
חשיפה לשערי חליפיןייצור בישראל, הכנסות בדולר
5 Analytical Lens — The Questions We Ask
In professional company analysis, the question is not "is this good?" but rather "through which lenses must this company be examined so that we do not miss what matters most?" At Bakshi Finance, every analysis passes through six lenses.

This framework is intended to structure analysis, not to produce an investment conclusion.
Growth
Revenue grew 172% over 5 years. How much is category demand (AI capex) versus market-share capture?
Profitability
Operating margin 39.7% — excellent. What is the ceiling? How does this compare to KLA (~36%)?
Leverage
Debt/Equity 0.05 — minimal leverage. Why the NIS 225M private placement? What is the use of proceeds?
Competitive Position
Qualitau leads in the niche. What is the advantage against Outermost Technology? How does KLA affect the picture?
Management Quality
Kobi Herschman (CEO since 1998), Nava Ben-Yehuda (CFO since 2004) — unusual stability. Is that stability an advantage or a disadvantage?
Business Complexity / Risk
A small company (72 employees), specific niche, a few-customer dependence. How should an investor assess "key-man" risk?
6 Scenario Framework
Scenarios are descriptive, not predictive. They outline possible conditions, not expected outcomes.
These scenarios carry no probability assessment, no preferred direction, and no expectation regarding which, if any, will materialise.
Constructive Scenario — if the following conditions hold:

AI/Advanced Packaging continues to demand new test methodologies, order backlog exceeds $80M, India expansion succeeds. Revenue grows 30%+ annually, operating margin 40%+.

Base Scenario — if current trends continue:

Revenue grows 15-20% annually, operating margins stable around 38-40%. Net income grows double-digit.

Adverse Scenario — if the following risks materialise:

Semi-cycle downturn, severe China export restrictions, or loss of a major customer. Revenue falls 10-20%, operating margins compress to 25-30%.

Scenarios describe conditions, not forecasts. There is no preferred direction and no probability assessment expressed in this framework.
7 How to Think About This Company
Qualitau is not a large semiconductor company — it is an example of what happens when a small Israeli company (72 employees, $61M revenue) becomes a global niche player. Qualitau’s model is distinctive: it does not compete with KLA or Applied Materials on the full market, but targets a niche (reliability testing) where it sells to the fabs of the majors. The real question in analysing Qualitau is not "is the company profitable" (it is — 40% operating margin), but rather "how large is the niche, and is growth sustainable given its ability to maintain the technological lead over time?"
The critical variables are three. First, order backlog. $57.6M at March 2025 = ~12 months of revenue. A growing backlog confirms 2026-2027 growth. Second, NIS 225M private placement. A 7.5% dilution — the rationale must be understood. If for a strategic acquisition, it creates value. If for stock-based compensation, a question mark. Third, Q4 2025 weakness. A drop from $21M to $12M in a single quarter — is it temporary (order timing) or a signal of moderation?
Where the analysis may go wrong. First error — treating 32.5% growth in 2025 as the standard. Quarters are highly volatile. Revenue concentration depends on 3-4 large customers. Second error — treating $4.81 EPS as steady-state. That reflects an exceptionally strong Q3; the run-rate is lower. Third error — assuming 40% margins persist. It is a high level for a small company.
What distinguishes professional analysis of Qualitau. Professional analysis addresses three things: (a) the ratio of recurring revenue (lab services, maintenance) to one-off (systems) revenue; (b) the total TAM in reliability testing — and Qualitau’s share; (c) the scenario of an anchor customer leaving — 20% of revenue loss is not hypothetical. These are not what one buys — they are what one asks before deciding.
The difference between surface-level analysis and professional thinking often lies in the variables that are not immediately visible.
The difference between surface-level analysis and professional thinking often lies in the variables that are not immediately visible.
8 Sources & Data
#SourceDateType
1קווליטאו — דוח Annual 2025March 2026Official — TASE
2מצגת Quarterlyת Q4 2025פברואר 2026Official
3maya.tase.co.il — QLTUApril 2026Official — Stock Exchange

Missing: Insider ownership מדויק, אופי הקצאה הפרטית 225M ₪ (פברואר 2026), תרומה לפי לקוח (TSMC, Samsung, Intel).

🔒

Premium Content — Qualified Investors Only

The full Qualitau (QLTU) analysis is available to Premium members of Bakshi Finance — Family Office.
The analysis includes a professional review across 8 structured sections, 6 charts and a framework of scenarios.

Unlock Analysis — $60 $60 per analysis · $900 / year for full access
10

Analytical Lens — The Questions We Ask

In professional company analysis, the question is not "is this good?" but rather "through which lenses must this company be examined so that we do not miss what matters most?" Every Bakshi Finance analysis passes through six lenses. The text below is not a judgement — it is a map of the questions this analysis is intended to answer.

The analysis is based on an internal multi-factor analytical framework used in professional portfolio management. The framework maps the questions; the answers appear woven through the analysis above.

What the lens is not: there is no rating, no score, no comparison between this company and another, and no preference expressed. The same six questions are asked of every company on the site — what varies is the answers, not the instrument.

This framework is intended to structure analysis, not to produce an investment conclusion.

📈
Growth
How is the company growing? Is the growth driven by volume, price, or mix? Is it stable across cycles?
💰
Profitability
How do margins behave over time? How much of reported earnings translates into genuine free cash flow?
⚖️
Leverage
What is the capital structure? How flexibly can the company navigate a down-cycle or a period of elevated financing costs?
🏰
Competitive Position
What protects its revenues from erosion? How long is that protection likely to endure?
👔
Management Quality
How does management allocate capital? What is their track record on strategic decisions?
🧩
Business Complexity / Risk
Where would a simplistic analysis go wrong? What is exposed to regulation, cyclicality, or technological change?

Key Observations

This summary is not a recommendation. It is a factual list of what the analysis has identified. The decision rests with the client.

Disclosure — Family Office

Bakshi Finance operates as a Family Office serving qualified investors only. Mr. Yaron Bakshi held a licensed investment-advisory practice from 2008 through 2023. As of the date of this publication, the firm does not hold an investment-advisory, investment-marketing or portfolio-management licence. This document is provided for research and professional education purposes only. Nothing herein constitutes a recommendation to buy, sell, hold or take any action with respect to any security. Nothing herein is a substitute for personalised advice based on an individual’s circumstances. All decisions remain the sole responsibility of the investor. Past performance is not indicative of future results.